|
CN105218514A
|
|
The preparation method of Zaltoprofen
|
|
CN105198776A
|
|
Edoxaban intermediate and preparation method thereof
|
|
CN105254670A
|
|
Preparation method of (R)-9-[2-(phosphonomethoxy) propyl] adenine
|
|
CN105198858A
|
|
Purification method of zaltoprofen
|
|
CN105153293A
|
|
Erythropoietin mimic peptide, dimer thereof, and preparation methods and application of erythropoietin mimic peptide and dimer
|
|
CN105130994A
|
|
Lixivaptan crystal form IV, preparation method and application thereof
|
|
CN104860872A
|
|
Bis-(3R,4R)-1-benzyl-N,4-dimethyl piperidin-3-amine L-di-p-toluyl tartrate synthesis method
|
|
CN104860919A
|
|
Piperidine-containing benzimidazole derivative, preparation method and uses thereof
|
|
CN104829629A
|
|
Sulfonamide-containing tetrahydrothieno[2,3-c] pyridine derivatives, preparing method thereof and uses of the derivatives
|
|
CN104678013A
|
|
Bevantolol hydrochloride isomer impurity detection method and application thereof
|
|
CN104530004A
|
|
Benzimidazole derivative and preparation method and use thereof
|
|
CN104558104A
|
|
Method for refining argatroban refining mother liquor recycling product
|
|
CN104529906A
|
|
Method for improving water solubility of hydroxybenzimidazolyl compound
|
|
CN104610123A
|
|
Preparation method of (S)-1-(2-chloroacetyl)pyrrolidine-2-formic acid
|
|
CN104557775A
|
|
Disulfamide phenothiazine compound, and preparation method and application thereof
|
|
CN104774245A
|
|
Preparation method and use of brain targeting peptide-antineoplastic drug conjugate
|
|
CN104230926A
|
|
Preparation method of minodronic acid key intermediate
|
|
CN105343053A
|
|
Application of Bavachin and Bavachalcone components in preparation of antidepressant drug
|
|
CN105348259A
|
|
Dabigatran etexilate oxaloacetate, preparation method and applications thereof
|
|
CN105348260A
|
|
Dabigatran etexilate hydrobromide, preparation method and applications thereof
|
